Asia · Regional markets · Pulse (Maeil Business)

Samsung Biologics raises 2026 revenue forecast to $4.1bn

Published by Pulse (Maeil Business) · South Korea 10 h ago

Samsung Biologics Co. raised its 2026 revenue forecast by 148.4 billion won ($111.9 million) to 5.47 trillion won, up 20 percent from last year, citing full utilization of Plants…

Read the full article on Pulse (Maeil Business) Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (pulse.mk.co.kr)

Also worth reading

CNBC-TV18

US 10-year yield falls below 5% as investors flock to havens

Business Standard

Jio Platforms IPO subscribed 5.57x on day 2; QIBs led with 13.29x bids

The Straits Times Business

TSH Resources reports 274 hot spots within estate boundaries after SGX queries over haze

The Business Times

Firms here should ‘act now’ to fix critical PHP vulnerabilities: Singapore’s cybersecurity chief

Tech in Asia

Indian AI startup ShopOS launches Sloosh content creation tool

Moneycontrol